PAK1 inhibition was observed to induce cell cycle arrest via the accumulation of lung cancer cells in the G1 phase [13], and significantly impair tumor growth in lung cancer xenograft models, indicating that PAK1 drives NSCLC tumor proliferation [14,15]. Here, PAK1 is linked to lung cancer.